Search for: "Bartlett v. Mutual Pharmaceutical Company"
Results 1 - 20
of 48
Sort by Relevance
|
Sort by Date
24 Sep 2018, 1:08 pm
Weyerhaeuser Company v. [read post]
17 Apr 2018, 8:33 am
Another 5-4 ruling by the highest court in Mutual Pharmaceutical Co. v. [read post]
15 Jan 2018, 11:40 am
Messing (2011) and Mutual Pharmaceutical Co. v. [read post]
1 Apr 2016, 3:02 am
March 23, 2016), and Barcal v. [read post]
31 Mar 2016, 3:00 am
The second paragraph cites the key sentence from Mutual Pharmaceutical Co. v. [read post]
9 Dec 2015, 6:50 am
Ct. 2567 (2011), and Mutual Pharmaceutical Co. v. [read post]
5 Jun 2015, 1:29 pm
See Mutual Pharm. [read post]
16 Oct 2014, 1:43 pm
Supreme Court’s decision in Mutual Pharmaceutical Co. v. [read post]
24 Sep 2014, 4:21 pm
Mensing and Mutual Pharmaceutical Co. v. [read post]
18 Jul 2014, 11:55 am
Wyeth Pharmaceuticals, Inc., 2008 WL 7136137 (Ala. [read post]
15 Apr 2014, 9:29 am
Mensing and Mutual Pharmaceuticals v. [read post]
5 Mar 2014, 2:46 pm
Mutual Pharmaceutical, U.S. [read post]
30 Dec 2013, 5:25 am
Mutual Pharmaceutical Co. v. [read post]
31 Oct 2013, 5:00 am
We think that the opinion resembles the First Circuit’s decision in Mutual Pharmaceutical Co. v. [read post]
11 Oct 2013, 1:36 pm
In Calisi v. [read post]
2 Oct 2013, 4:30 am
The plaintiffs had no response save a rather silly one – that there is no instance of the FDA striking a black box warning used by a pharmaceutical company. [read post]
19 Sep 2013, 9:53 am
By itself, off-label promotion is no more causal than, as we commented the other day, a “video of a company employee kicking his dog. [read post]
5 Sep 2013, 12:24 pm
It appears from the opinion, id., that the defendant tried to extend Mensing/Mutual Pharmaceutical Co. v. [read post]
23 Aug 2013, 3:27 am
Extending the monopolies of brand-name companies in this way reportedly costs consumers more than $3.5 billion per year.2 Since such settlements suppress competition, the Court sent the case back to the district court to be evaluated according to the “rule of reason,” one of the standards for determining whether an action violates antitrust law.Second, in Mutual Pharmaceutical v. [read post]
27 Jul 2013, 5:00 am
The subject is preemption – specifically the the United States Supreme Court’s recent ruling in Mutual Pharmaceutical Company, Inc. v. [read post]
